Fresenius | FRE - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Akzo Nobel EUR 2.76B 1.14B 2026-03
Alcon AG USD 1.58B 80M 2026-03
AstraZeneca USD 4.89B 2.67B 2026-06
BASF EUR 7.8B 4.71B 2026-06
Bayer EUR 4.29B 1.44B 2026-06
Beiersdorf EUR 1.2B 33M 2025-12
DaVita Healthcare Partners USD 668.96M 24.72M 2026-06
Demant DKK 1.33B 188M 2025-12
E.ON EUR 4.87B 1.83B 2026-03
Essilor EUR 3.54B 758M 2025-12
Fresenius EUR 2.06B 752M 2026-03
Fresenius Medical Care EUR 1.06B 177.89M 2026-06
Getinge SEK 2.05B 909M 2026-06
Givaudan CHF 603M 3M 2024-06
GlaxoSmithKline GBP 3.44B 292M 2026-03
GN Store Nord DKK 865M 254M 2026-03
GRIFOLS EUR 513M 189M 2026-06
Hikma Pharmaceutical USD 217M 19M 2025-12
Lonza CHF 719M 188M 2025-12
Merck EUR 2.74B 415M 2026-03
Novartis USD 7.62B 739M 2026-06
Philips EUR 1.79B 803M 2026-06
Roche Holding CHF 7.55B 579M 2025-06
RWE EUR 6.86B 873M 2026-03
Sanofi EUR 6.35B 806M 2026-06